Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern
Wenjuan Du, Daniel L. Hurdiss, Dubravka Drabek, et al.
Science Immunology (2022) Vol. 7, Iss. 73
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Monoclonal antibody therapies against SARS-CoV-2
Daniele Focosi, Scott A. McConnell, Arturo Casadevall, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 11, pp. e311-e326
Open Access | Times Cited: 214
Omicron BA.2 (B.1.1.529.2): High Potential for Becoming the Next Dominant Variant
Jiahui Chen, Guo‐Wei Wei
The Journal of Physical Chemistry Letters (2022) Vol. 13, Iss. 17, pp. 3840-3849
Open Access | Times Cited: 83
Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody
Sanjeev Kumar, Anamika Patel, Lilin Lai, et al.
Science Advances (2022) Vol. 8, Iss. 40
Open Access | Times Cited: 36
Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies
Qingrui Huang, Xiaonan Han, Jinghua Yan
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2412-2422
Open Access | Times Cited: 30
Single-Molecule Investigation of the Binding Interface Stability of SARS-CoV-2 Variants with ACE2
Ankita Ray, Tran Thi Minh Thu, Rita dos Santos Natividade, et al.
ACS Nanoscience Au (2024) Vol. 4, Iss. 2, pp. 136-145
Open Access | Times Cited: 8
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-COV-2 Variants
Lingyan Cui, Tingting Li, Wenhui Xue, et al.
(2024)
Open Access | Times Cited: 6
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron
Huan Ma, Xinghai Zhang, Peiyi Zheng, et al.
Cell Research (2022) Vol. 32, Iss. 9, pp. 831-842
Open Access | Times Cited: 28
A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein
Vito Thijssen, Daniel L. Hurdiss, Oliver J. Debski-Antoniak, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 26
Open Access | Times Cited: 15
Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants
Lingyan Cui, Tingting Li, Wenhui Xue, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 900-900
Open Access | Times Cited: 5
An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization
Fu‐Fei Hsu, Kang-Hao Liang, Monika Kumari, et al.
International Journal of Pharmaceutics (2022) Vol. 627, pp. 122256-122256
Open Access | Times Cited: 19
Humoral immunity for durable control of SARS-CoV-2 and its variants
Ryutaro Kotaki, Saya Moriyama, Yoshimasa Takahashi
Inflammation and Regeneration (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 11
An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike
Banghui Liu, Xuefeng Niu, Yijun Deng, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114265-114265
Open Access | Times Cited: 4
Neutralizing antibodies reveal cryptic vulnerabilities and interdomain crosstalk in the porcine deltacoronavirus spike protein
Wenjuan Du, Oliver J. Debski-Antoniak, Dubravka Drabek, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation
Saskia C. Stein, Guido Hansen, George Ssebyatika, et al.
Journal of Virology (2024)
Open Access | Times Cited: 4
Respiratory long COVID in aged hamsters features impaired lung function post-exercise with bronchiolization and fibrosis
L. Heydemann, Małgorzata Ciurkiewicz, Theresa Störk, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
A bivalent spike-targeting nanobody with anti-sarbecovirus activity
Iris C. Swart, Oliver J. Debski-Antoniak, Aneta Zegar, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Exploring the SARS-CoV-2 spike protein destabilizer toxin from the scorpion, spider, and wasp group of toxins as a promising candidate for the identification of pharmacophores against viral infections.
Mousa O. Germoush, Maged Fouda, Mohammad Jaffar Sadiq Mantargi, et al.
PubMed (2025) Vol. 15, Iss. 1, pp. 69-84
Closed Access
Anti-S2 antibodies responsible for the SARS-CoV-2 infection-induced serological cross-reactivity against MERS-CoV and MERS-related coronaviruses
Siyuan Sun, Jiaying He, L. Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody
Myeongsang Lee, Marian Major, Huixiao Hong
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3774-3774
Open Access | Times Cited: 9
A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy
Lu Meng, Jialu Zha, Bingjie Zhou, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 1, pp. e1011085-e1011085
Open Access | Times Cited: 9
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants
Cheng‐Pu Sun, Chi-Wen Chiu, Ping‐Yi Wu, et al.
Molecular Therapy (2023) Vol. 31, Iss. 11, pp. 3322-3336
Open Access | Times Cited: 8
Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD
Hui Sun, Tingting Deng, Yali Zhang, et al.
Protein & Cell (2023) Vol. 15, Iss. 2, pp. 121-134
Open Access | Times Cited: 7
High throughput identification of human monoclonal antibodies and heavy-chain-only antibodies to treat snakebite
Julien Slagboom, A. Lewis, Wietse M. Schouten, et al.
Toxicon X (2024) Vol. 21, pp. 100185-100185
Open Access | Times Cited: 2
Seasonal human coronaviruses OC43, 229E, and NL63 induce cell surface modulation of entry receptors and display host cell-specific viral replication kinetics
Vinayakumar Siragam, Mariam Maltseva, Nicolas Castonguay, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 7
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top